Saroja Pharma Industries India Limited (NSE:SAROJA)
India · Delayed Price · Currency is INR 33.00
0.00 (0.00%)
Jun 22, 2026, 3:29 PM IST
NSE:SAROJA Revenue
In the fiscal year ending March 31, 2026, Saroja Pharma Industries India had annual revenue of 701.29M INR with 30.53% growth. Saroja Pharma Industries India had revenue of 317.69M in the half year ending March 31, 2026, with 62.50% growth.
Revenue
701.29M
Revenue Growth
+30.53%
P/S Ratio
0.19
Revenue / Employee
58.44M
Employees
12
Market Cap
132.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 701.29M | 164.02M | 30.53% |
| Mar 31, 2025 | 537.27M | 130.58M | 32.11% |
| Mar 31, 2024 | 406.69M | -95.24M | -18.97% |
| Mar 31, 2023 | 501.93M | -54.39M | -9.78% |
| Mar 31, 2022 | 556.33M | 189.71M | 51.75% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Visaman Global Sales | 2.49B |
| De Neers Tools | 1.78B |
| Aspire & Innovative Advertising | 1.76B |
| Prizor Viztech | 1.48B |
| Rockingdeals Circular Economy | 1.20B |
| Khaitan (India) | 1.12B |
| Silkflex Polymers (India) | 1.10B |
| Anlon Technology Solutions | 1.06B |